0Suppliers
3Customers
3Debt Items
20Related Chains

Verastem, Inc. Suppliers

No suppliers on recordVerastem, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Verastem, Inc. Customers

TickerNameConfidenceEvidence
PANCREATIC-CANCER-NETWORK PANCREATIC-CANCER-NETWORK 92% For the three months ended March 31, 2026, there were two customers who each individually accounted for greater than 10% of the Company’s total revenues. These two customers accounted for revenues of…
SNYNF Sanofi 72% cell lymphoma and a payment of $ million upon receipt of the first regulatory approval for the commercial sale of COPIKTRA in the European Union for the treatment of peripheral T-cell lymphoma, (ii) …
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: cell lymphoma and a payment of $ million upon receipt of the first regulatory approval for the commercial sale of CO…

Verastem, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
VSTM-DEBT-13454 Warrants outstanding: 33792000 90% xbrl warrant detail from xbrl 2025-12-31.
VSTM-DEBT Debt stack $85.5M 90% Market cache reports total debt of $85.5M.
VSTM-DEBT-13455 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Verastem, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Verastem, Inc..

Verastem, Inc. Ownership

HolderNameConfidenceEvidence
VSTM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 157 tracked holders.

Verastem, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2